Rohan Narayan

This paper develops AFMT analogs that inhibit gut bacterial L-dopa decarboxylases while reducing susceptibility to host metabolism.

This paper describes a modular, adjuvant-free mucosal vaccine platform that elicits broad T cell immunity against multiple Influenza A virus strains.

This paper shows that combining Auranofin and Remdesivir synergistically inhibits SARS-CoV-2 in vitro and in animal models.

This study identifies strain-specific virulence mechanisms in IAV and proposes a combination therapy using Oseltamivir and Baricitinib to reduce inflammation and improve survival in a murine model.

This study identifies DUB inhibitors that target SARS-CoV-2 PLpro, inhibiting its proteolytic activity and restoring immune responses in a mouse model.